Drugs / Alk (225) Phleum Pratense
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02255604 Comparator | Aug 2013 → Sep 2015 | allergic disease | University of Aarhus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alk (225) Phleum Pratense | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02255604 ↗ |
| Route | Other | “Patients are injected with 3 or 4 doses of alk 225 Phleum Pratense 1000 standard quantity units/ml in a lymph node in the groin.” NCT02255604 ↗ |